Antioxidant therapy attenuates oxidative insult caused by benzonidazole in chronic Chagas' heart disease

International Journal of Cardiology

Volumn 145, Issue 1, 2010, Pages 27-33

  Ribeiro, Carine Muniz ^a   Budni, Patricia ^a   Pedrosa, Roberto Coury ^b   Farias, Mirelle Sifroni ^a   Parisotto, Eduardo Benedetti ^a   Dalmarco, Eduardo Monguilhott ^a   Fröde, Tania Silva ^a   Oliveira Silva, Diogo ^c   Colepicolo, Pio ^c   Filho, Danilo Wilhelm ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antioxidant supplementation; Benzonidazole; Cardiopathy; Chagas' disease; Oxidative stress; Vitamin E

Indexed keywords

ADENOSINE DEAMINASE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BENZNIDAZOLE; CATALASE; E TABS; ENERGIL C; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; MYELOPEROXIDASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CHAGAS DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HEART DISEASE; HEMODYNAMICS; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; STATISTICAL SIGNIFICANCE; SUPPLEMENTATION; TREATMENT DURATION; TRYPANOSOMA CRUZI;

ANTIOXIDANTS; ASCORBIC ACID; CHAGAS DISEASE; CHRONIC DISEASE; HUMANS; NITROIMIDAZOLES; OXIDATIVE STRESS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMIN E;

EID: 77955417258     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.06.033     Document Type: Article

References (56)

1. WHO Control of Chagas' disease: Second Report of the WHO Expert Committee Technical Report Series 2002 World Health Organization Geneva, Switzerland
2. Guhl G, lazdins-Helds KJ. editors. Grupo de trabajo científico sobre la enfermedad de Chagas. Buenos Aires, Argentina. 2007. Programa Especial de Investigaciones y Enseeñanzas sobre Enfermedades Tropicales (TDR). Sponsored by UNICEF, PNUD, Banco Mundial and WHO.
3. J.C. Dias, A.C. Silveira, and C.J. Schofield The impact of Chagas' disease control in Latin America: a review Mem Inst Oswaldo Cruz 97 2002 603 612
4. B. Bern, S.P. Montgomery, and B.L. Herwaldt Evaluation and treatment of Chagas' disease in the United States: a systematic review JAMA 298 2007 2171 2181
5. J.A. Marin-Neto, A. Rassi Jr, and C.A. Morillo Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The Benznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT) Am Heart J 156 2008 37 42
6. Tratamiento etiológico de la enfermedad de Chagas. Conclusiones de una Consulta Técnica. Washington, DC, Pan American Health Organization, 1999 (document OPS/HCP/HCT/140/99; available on request from Communicable Diseases, Pan American Health Organization, Washington, DC 20037, USA).
7. A.M. Castro, A.O. Luquetti, and A. Rassi Detection of parasitemia profiles by blood culture after treatment of human chronic Trypanosoma cruzi infection Parasitol Res 99 2006 379 383
8. R. Viotti, C. Viigliano, H. Armenti, and E. Segura Treatment of chronic Chagas 'disease with benznidazole: clinical and serologic evolution of patients with long-term follow up Am Heart J 127 1994 151 162
9. R. Viotti, C. Vigliano, and B. Lococo Long-term cardiac outcomes of treating chronic CD with benznidazole versus no treatment: a nonrandomized trial Ann Int Med 144 2006 724 734
10. S. Garcia, C.O. Ramos, and J.F.V. Senra Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations Antimicrob Agents Chemother 49 2005 1521 1527
11. R. DoCampo, and S.N.J. Moreno Free-radical intermediates in the antiparasitic action of drugs and phagocytic cells Free Radic Biol Med 6 1984 243 288
12. J.D. Maya, B.K. Cassels, and P. Iturriaga-Vásquez Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host Comp Biochem Physiol 146 2007 601 620
13. N.J. Temperton, S.R. Wilkinson, D.J. Meyer, and J.M. Kelly Overexpression of superoxide dismutase in Trypanosoma cruzi results in increased sensitivity to the trypanocidal agents gentian violet and benznidazole Mol Biochem Parasitol 96 1998 167 176
14. F.B. Nogueira, M.A. Krieger, and P. Nirdé Increased expression of iron containing superoxide dismutase-A (TcFeSODA) enzyme in Trypanosoma cruzi population with in vitro-induced resistance to benznidazole Acta Trop 100 2006 119 132
15. A. Boveris, H. Sies, and E.E. Martino Deficient metabolic utilization of hydrogen peroxide in Trypanosoma cruzi Biochem J 188 1980 643 648
16. J.A. Castro, M.M. Mecca, and L.C. Bartel Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis) Hum Exp Toxicol 25 2006 471 479
17. R.C. Pedrosa, A. De Bem, and C. Locatelli Time-dependent oxidative stress caused by benznidazole Redox Report 6 2001 265 270
18. K. Hensley, K.A. Robinson, and S. Prasad Gabbita Reactive oxygen species, cell signaling, and cell injury Free Radic Biol Med 28 10 2000 1456 1462
19. M.A. Zacks, J.J. Wen, and G. Vyatkina An overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress An Acad Bras Cienc 77 4 2005 695 715
20. T.B. Oliveira, R.C. Pedrosa, and D. Wilhelm Filho Oxidative stress in chronic cardiopathy associated with Chagas' disease Int J Cardiol 116 2007 357 363
21. L. Villacorta, A. Azzi, and J.M. Zingg Regulatory role of vitamins E and C on extracellular matrix components of the vascular system Mol Aspects Med 28 2007 507 537
22. M.G. Traber Vitamin E regulatory mechanisms Annu Rev Nutr 27 2007 347 362
23. J.M. Zingg Vitamin E: an overview of major research directions Mol Aspects Med 28 2007 400 422
24. L.B. Maçao, D. Wilhelm Filho, and R.C. Pedrosa Antioxidant therapy attenuates oxidative stress in chronic cardiopathy associated with Chagas' disease Int J Cardiol 123 2007 43 49
25. H.A. Carrasco Diagnóstico de daño miocárdico en la enfermedad de Chagas. Textos de la Universidad de Los Andes: Cosenjo de Publicaciones de la Universidad de Los Andes, Merida 1983
26. H. Aebi Catalase in vitro Methods Enzymol 204 1984 234 254
27. H.P. Misra, and I. Fridovich The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase J Biol Chem 247 1972 188 192
28. I. Calberg, and B. Mannervik Glutathione reductase from rat liver Methods Enzymol 113 1985 484 490
29. L. Flohé, and W.A. Gunzler Assays of glutathione peroxidase Methods Enzymol 105 1984 114 121
30. W.H. Habig, M.J. Pabst, and W.B. Jacoby Glutathione S-transferases: the first enzymatic step in mercapturic acid formation J Biol Chem 249 1976 7130 7139
31. E. Beutler, O. Duron, and B.M. Kelly Improved method for the determination of blood glutathione J Lab Clin Med 61 1963 882 890
32. R.L. Levine, D. Garland, and C.N. Oliver Determination of carbonyl content in oxidatively modified proteins Methods Enzymol 186 1990 464 478
33. R.P. Bird, and A.H. Draper Comparative studies on different methods of malondyhaldehyde determination Methods Enzymol 90 1984 105 110
34. G. Nicoletti, L. Crescibene, and M. Scornaienchi Plasma levels of vitamin E in Parkinson's disease Arch Gerontol Geriatr 33 2001 7 12
35. T.S. Fröde, J.B. Calixto, and Y.S. Medeiros Analysis of the inflammatory response induced by substance P in the mouse pleural cavity Peptides 20 1999 259 265
36. T.S. Rao, J.L. Currie, A.L. Shaffer, and P.C. Isakson Comparative evaluation of arachidonic acid (aa)- and tetradecanoylphorbol acetate (tpa)-induced dermal inflammation Inflammation 17 1993 723 741
37. T.S. Fröde, and Y.S. Medeiros Myeloperoxidase and adenosine deaminase levels in the pleural fluid leakage induced by carrageenan in the mouse model of pleurisy Mediat Inflamm 10 4 2001 223 227
38. G. Giusti, and B. Galanti Adenosine deaminase: colorimetric method HU Bergmeyer, Methods of enzymatic analysis 1984 Verlag Chemie New York 315 323
39. R. Pèrez-Fuentes, J.F. Guegan, and C. Barnabe Severity of chronic Chagas' disease is associated with cytokine/antioxidant imbalance in chronically infected individuals Int J Parasitol 33 2003 293 299
40. R. Sathler-Avelar, D.M. Vitelli-Avelar, and R.L. Massara Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern Microbes Infect 10 2008 103 113
41. R. Sathler-Avelar, D.M. Vitelli-Avelar, and R.L. Massara Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile Scand J Immunol 64 2006 554 563
42. R.C.N. Melo, D.L. Fabrino, and H. D' Ávila Production of hydrogen peroxide by peripheral blood monocytes and specific macrophages during experimental infection with Trypanosoma cruzi in vivo Cell Biol Int 27 2003 853 861
43. O. Cachia, J. El Benna, and E. Pedruzzi α-Tocopherol inhibits the respiratory burst in human monocytes J Biol Chem 273 49 1998 32801 32805
44. M.G. Traber, and J. Atkinson Vitamin E, antioxidant and nothing more Free Radic Biol Med 43 2007 4 15
45. Z.G.M. Lacava, and H. Luna The anticlastogenic effect of tocopherol in peritoneal macrophages of benznidazole-treated and ovariectomized mice Mutat Res 305 2 1994 145 150
46. D.J. Mustacich, K. Gohil, and R.S. Bruno Alpha-tocopherol modulates genes involved in hepatic xenobiotic pathways in mice J Nutr Biochem 16 1 2005 23 30
47. C.K. Chow Glucose and dietary vitamin E protection against catalase inactivation in the red cells of rats Int J Vitam Nutr Res 50 4 1980 364 369
48. C.K. Chow Oxidative damage in the red cells of vitamin E-deficient rats Free Radic Res Commun 16 4 1992 247 258
49. L.S.C. Carvalho, E.R.S. Camargos, and C.T. Almeira Vitamin E deficiency enhances pathology in acute Tripanosoma cruzi-infected rats Trans R Soc Trop Med Hyg 100 11 2006 1025 1031
50. F. Shang, X. Gong, and S. Egtesadi Vitamin C prevents hyperbaric oxygen-induced growth retardation and lipid peroxidation and attenuates the oxidation-induced upregulation of glutathione in guinea pigs J Nutr Biochem 13 2002 307 313
51. 2 Free Radic Biol Med 34 5 2003 521 530
52. B. Halliwell, and J.M.C. Gutteridge Free radicals in biology and medicine 3rd ed. 2001 Oxford University Press Oxford
53. T. Motoyama, H. Kawano, and K. Kugiyama Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina J Am Coll Cardiol 32 6 1998 1672 1679
54. M. Naviliat, G. Gualco, A. Cayota, and R. Radi Protein 3-nitrotyrosine formation during Trypanosoma cruzi infection in mice Braz J Med Biol Res 38 2005 1825 1834
55. O. Erel, A. Kocyigit, and M.S. Gurel Adenosine deaminase activities in sera, lymphocytes and granulocytes in patients with cutaneous leishmaniasis Mem Inst Oswaldo Cruz 93 4 1998 491 494
56. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150